Standardizing Image Acquisition Jeffrey L. Evelhoch, PhD Director Medical Sciences (Imaging)

Slides:



Advertisements
Similar presentations
Guidelines for a standardized MRI protocol for MS:
Advertisements

Neuroradiology Natasha Wehrli, MS4 University of Pennsylvania School of Medicine.
Multivendor, Multisite DCE-MRI Phantom Validation Study Edward Jackson 1, Edward Ashton 2, Jeffrey Evelhoch 3, Michael Buonocore 4, Greg Karczmar 5, Mark.
ACRIN 6698 Protocol: Diffusion-weighted MR Imaging Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: A sub-study of the ISPY-2.
Section 1 fMRI for Newbies
Neuroradiology Dr Mohamed El Safwany, MD. Intended Learning Outcomes  The student should be able to understand role of medical imaging in the evaluation.
Synopsis of FDA Colorectal Cancer Endpoints Workshop Michael J. O’Connell, MD Director, Allegheny Cancer Center Associate Chairman, NSABP Pittsburgh, PA.
NZIMRT Conference The BasicsThe Basics  Equipment required  Clinical Indications  Patient Preparation  Sequences  Image Appearances.
Terry M. Button, Ph.D. Principals of Magnetic Resonance Image Formation.
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
16 November 2004Biomedical Imaging BMEN Biomedical Imaging of the Future Alvin T. Yeh Department of Biomedical Engineering Texas A&M University.
PHYSICS IN NUCLEAR MEDICINE: QUANTITAITVE SPECT AND CLINICAL APPLICATIONS Kathy Willowson Department of Nuclear Medicine, Royal North Shore Hospital University.
A novel technique has been proposed for dynamic MRI: Dynamic KWIC Permits image reconstruction at both high spatial and high temporal resolutions Technique.
Clinical Trials The Way We Make Progress Against Disease.
Gd: MR Venography Martin R. Prince, MD, PhD. Strategies to reduce Gd Dose shorten scan duration time bolus for center of k-space digital subtraction higher.
Introduction to Nuclear Medicine
AMERICAN COLLEGE OF RADIOLOGY March 23, OUR MISSION To foster the ongoing development of widely acceptable consistent imaging.
ACRIN 6657/CALGB Consent for Research Study Contrast-Enhanced Breast MRI and MRS: A Correlative Science Studies to Characterize Tumor Response in.
M. D. A NDERSON Cancer Center Magnetic Resonance Imaging: 4.7 T, 40 cm Bruker Biospec James A Bankson, Ph.D. and John D Hazle, Ph.D. Small Animal Cancer.
Consent for Research Study A study for patients with a diagnosis of liver cancer who are on the waiting list for a liver transplant Comparison of advanced.
The comparison of MRI imaging In 3.0 T & 1.5T By a.r.shoaie.
Protocol Complexity as a Factor in Vendor Management Compliance Risk
Future Of Diagnostic Imaging A Look Into The Next Decade ? (Part 3)
International Atomic Energy Agency L 4 PROTECTION ISSUES IN CLINICAL METHODOLOGY.
The Clinical Guide “A Guide to Implementing Renal Best Practice in Haemodialysis“ Chapter 5: Anticoagulation Team Leader: Angela Henson Co-authors: Franta.
1 R2 ImageChecker CT CAD PMA: Clinical Results Nicholas Petrick, Ph.D. Office of Science and Technology Center for Devices and Radiological Health U.S.
Purpose of the Interactive Breath-Hold Control System To improve CT-guided biopsies of the lung or upper abdomen by allowing consistent, optimal visualization.
BIOMEDICAL IMAGING PROGRAM NATIONAL CANCER INSTITUTE.
PREPARATION FOR A MONITORING VISIT KEMRI-Wellcome Trust Research Programme Version: 4-Nov-2008.
The Quantitative Imaging Network (QIN) Robert Nordstrom, Ph.D. Larry Clarke, Ph.D.
Revision Dr Mohamed El Safwany, MD.. Liver CT Blood circulation in the liver comprises two major components: the hepatic artery and the portal vein. After.
Imaging Core Laboratory Fall Meeting, 2011 Imaging Challenges for ACRIN sites Compliance and set-up Anthony M. Levering Assistant Director, Core lab.
Update From FDA: Office of the Commissioner and Center for Drug Evaluation and Research Janet Woodcock, M.D. Acting Deputy Commissioner for Operations.
The basic story – fMRI in 25 words or less!. fMRI Setup.
OEWG Kick-Off Meeting Meg Mooney, MD Chief, Clinical Investigations Branch CTEP, DCTD, NCI – March 24, 2010 CTEP & Cooperative Group Plans for OEWG Implementation:
Review of Ultrasonic Imaging
Successful Concepts Study Rationale Literature Review Study Design Rationale for Intervention Eligibility Criteria Endpoint Measurement Tools.
Metals in Medicine Consortium Sydney Cancer Centre.
SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.
Preclinical Guidelines: Development of Radioprotective/Mitigative Agents Departments of Dermatology & Radiation Oncology University of Rochester Medical.
FDA Case Studies Pediatric Oncology Subcommittee March 4, 2003.
Clinical Assessment Program for Residencies Jim Czarnecki, D.O.
1 THE ROLE OF COVARIATES IN CLINICAL TRIALS ANALYSES Ralph B. D’Agostino, Sr., PhD Boston University FDA ODAC March 13, 2006.
Perfusion MRI in GSK Study
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
Magnetic Resonance Imaging
MRI CASE Done By: Haya Al-Thuwaini Ro’aa Al-Nemer Kholoud Al-Washmi Prepared For: Dr.Halima,,
How To Design a Clinical Trial
FDA’s Public Workshop: Innovative Systems for Delivery of Drugs and Biologics: Scientific, Clinical, and Regulatory Challenges Paul Goldfarb, MD, FACS.
MRI-Based Assessment of Neovasculariation in Carotid Plaque – A Novel Risk Marker for Plaque Rupture Michael Jerosch-Herold, PhD Associate Professor of.
QIBA DCE-MRI Technical Committee Jeffrey L. Evelhoch, PhD Executive Director, Medical Sciences Head, Imaging Sciences MEDICAL IMAGING CONTINUUM Path Forward.
C-1 Pegfilgrastim (Neulasta  ) Oncologic Drugs Advisory Committee Pediatric Subcommittee October 20, 2005 Amgen Inc.
DTI Acquisition Guide Donald Brien February 2016.
Biomarkers from Dynamic Images – Approaches and Challenges
Monday Case of the Day A) The treatment was successful: The bremsstrahlung SPECT (Fig 2) indicates that 90 Y was deposited in the tumor. B) The treatment.
Tuesday Case of the Day History: Clinical history of known invasive ductal carcinoma. Contrast-enhanced magnetic resonance imaging (CE-MRI) is the current.
Basics of Perfusion Imaging With Dynamic Contrast MRI Larry Panych, PhD Brigham and Women’s Hospital.
Chapter 12 Therapeutic Heating Applications of Radio Frequency Energy C-K. Chou.
Chapter 5 Mark D. Herbst, M.D., Ph.D.. The MR Imaging Process Two major functions –Acquisition of RF signals –Reconstruction of images.
Sayed Ali Mus POST GRADUATES-BATCH 6 FACULTY OF MEDICAL LABORATORY SCIENCES PARASITOLOGY DEPARTMENT ALNEELIN UNIVERSITY March 2015 Symposium on: Advances.
He-Kwon Song, PhD Associate Professor & Co-investigator in the CMROI, Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia,
Imaging of Small Vessels in the Brain using MRI
How To Design a Clinical Trial
FMRI data acquisition.
Radiological Sciences Department Ph.D., Paris-Sud 11 University
Sunday Case of the Day Physics (Case 1: MR)
Quantitative analysis
Development Plans: Study Design and Dose Selection
Basics of fMRI and fMRI experiment design
The echo time (TE) The echo time (TE) refers to the time between the application of the radiofrequency excitation pulse and the peak of the signal induced.
Presentation transcript:

Standardizing Image Acquisition Jeffrey L. Evelhoch, PhD Director Medical Sciences (Imaging)

2 Why standardize acquisition? Best Image Processing Ever

3 Issues to consider Manufacturer-based differences Technology changes Not all sites are created equal QC for quantitative v. diagnositic imaging Appropriate method depends on: –Exact question –Image analysis methods Who will ‘mind the shop’

4 An Example – Consensus Protocol DCE-MRI Early phase clinical trials for drugs targeting tumor blood supply Low molecular weight gadolinium chelates 1.5 Tesla

5 A Brief History October 1999: NCI Workshop  consensus recommendation –Included both treatment response and breast diagnosis March 2002: CRUK PTAC Workshop  consensus recommendation –Treatment response in early clinical trials Nov 2004: NCI Workshop  consensus recommendation –Treatment response in early clinical trials

6 NCI Workshop Participants Jeffrey Abrams Thomas Chenevert Laurence Clarke Jerry Collins Jeffrey Evelhoch Susan Galbraith Michael Knopp Jason Koutcher Martin Leach Nina Mayr Daniel Sullivan Edward Ashton Peter Choyke Patricia Cole Gregory Curt Milind Dhamankar Michael Jacobs Gary Kelloff Adrian Knowles Lester Kwock Peter Martin Teresa McShane Anwar Padhani Stefan Roell Mark Rosen Gregory Sorensen Charles Springer Michael Tweedle Donald Williams Antonio Wolff

7 Specific recommendations for Type of measurement Requirements for contrast agent injection Primary endpoints Secondary endpoints Nomenclature Data reduction Region of interest Images acquired prior to contrast injection Dynamic acquisition protocol Measurement requirements for primary endpoints Trial design Image analysis

Let’s consider issues & approaches adopted to address those issues

9 Manufacturer-based differences e.g., Sequence names SequenceGEPhilipsSiemens Gradient echoGRASSFFEGRE Spoiled Gradient echo SPGRT1FFEFLASH Inversion Recovery MPIRIR-TSETurboIR

10 Approaches Need access to experts on all systems Use basic sequences (differences smaller) Tweak parameters to match as closely as possible Make certain reconstruction methods are as close as possible Same reference standard on all systems

11 Technology changes  keep it simple 1.5-T (for near future) Basic sequences (less likely to change with upgrades) Parameters (at least) one step back from cutting edge Use analysis with considerable experience within community, most forgiving Revisit recommendations periodically

12 Not all sites are created equal Keep it simple Training, training, training, … Routine QC Careful monitoring Immediate feedback

13 QC for quantitative v. diagnositic imaging Requires higher performance –MR system –Sequences –Set-up procedures –Radiological processes Better here or here?

14 Appropriate method For breast cancer diagnosis want dynamic temporal-spatial resolution trade-off M. Schnall, MRM 2001

15 Who will ‘mind the shop’?

Summary of key recommendations for data acquisition

17 General Issues Entry criteria should consider tumor size in relation to pharmacological mechanisms, MRI resolution, sensitivity to motion and potential confounding factors from previous treatment (e.g., radiation) or rapid tumor growth rates Tumors in a fixed superficial location should be at least 2 cm in diameter; other tumors should be at 3 cm in diameter Adjust orientation so that motion is in-plane when motion effects cannot be avoided (e.g., liver, lungs)

18 Pre-injection Acquire high quality clinical images of entire anatomic region (preferably in two orthogonal planes) Acquire T1- and T2-weighted images registered in the same planes as the dynamic data If possible, measure T1 (using same resolution and field of view for dynamic data)

19 Contrast agent injection Use power injector to minimize variation Injection dose should be standardized by weight sec for total injection, at least 20 cc saline flush Document injection site, use same site for subsequent studies in same subject Minimum of 24 h between studies

20 Dynamic study (I) For first 150 sec after bolus injection, use fastest sampling possible consistent with spatial resolution/anatomic coverage requirements, but not slower than 20 sec temporal resolution

21 Dynamic study (II) Acquire data out to at least 8 min (continual sampling is optional) If possible, include in imaging volume a normalization function (e.g., arterial or other tissue) For serial studies, imaging volume of interest should be adjusted to sample same region of tumor

22 Summary Development & application of appropriate protocol requires close academic-industry interaction For multi-center studies –Keep it as simple as possible while still getting the required info –Clarity & education up front is essential –Non-standard methods require substantial continuous support